Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| CEM-SS | IC50 | 20.1 μM | Compound was evaluated for the cytoprotection of CEM-SS cells by XTT cytoprotection assay through the NCI AIDS Screen | [PMID: 10212126] |
| MT4 | CC50 | 115 μM | Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay | [PMID: 20541944] |
| MT4 | CC50 | 115 μM | Cytotoxicity against human MT4 cells by MTT assay | [PMID: 18243421] |
| MT4 | EC50 | 12.7 μM | Cytotoxicity gainst human MT4 cells after 3 days by MTT assay | [PMID: 20541944] |
| MT4 | EC50 | 12.7 μM | Antiviral activity against HIV1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay | [PMID: 18243421] |
| MT4 | IC50 | 45 μM | Concentration of compound required to reduce MT-4 cell viability by 50% | [PMID: 10212126] |
| MT4 | EC50 | 5.3 μM | Concentration of compound required to protect 50% of MT-4 cells against retroviral cytopathic effects by HIV-1 (IIIa) | [PMID: 10212126] |